GSK plc directors purchased ordinary shares and ADS on September 18, 2026, including 1,500 ordinary shares at £18.8110 and 1,734 ADS at $49.8534. The transaction details give investors named participants, instruments, prices and trading venues for the reported director share purchases.

Key Highlights

  • Sir Jonathan Symonds purchased 1,500 GSK ordinary shares at £18.8110 each.
  • Charles Bancroft purchased 1,734 GSK American Depositary Shares at $49.8534 each.
  • The reported purchases took place on September 18, 2026, on the London Stock Exchange and New York Stock Exchange.

GSK plc (NYSE: GSK) is a Pharmaceuticals: Major company. On September 18, 2026, Sir Jonathan Symonds bought 1,500 ordinary shares at £18.8110 each, while Charles Bancroft purchased 1,734 American Depositary Shares at $49.8534 each. The purchases took place on the London Stock Exchange and New York Stock Exchange, respectively.

GSK Share Purchases Span London and New York

The London transaction covered ordinary shares, while the New York transactions involved American Depositary Shares. Elizabeth (Liz) McKee Anderson, Dr Anne Beal, Dr Hal Dietz, Dr Jeannie Lee and Dr Vishal Sikka also purchased ADS on the New York Stock Exchange. Roy Jackobs purchased ordinary shares on the London Stock Exchange. Each transaction was recorded separately as a single transaction. Symonds is identified as Non-Executive Chair.